140 likes | 245 Views
Lead Analyst: Charles Paraboschi | Associates: Robert Kost & Peter Blicharz. Humana, Inc. (HUM). Healthcare (Health care providers). Investment Thesis. Best positioned in new healthcare environment Accelerated enrollment growth Recent acquisition and new contract open new markets
E N D
Lead Analyst: Charles Paraboschi| Associates: Robert Kost & Peter Blicharz Humana, Inc. (HUM) Healthcare (Health care providers)
Investment Thesis • Best positioned in new healthcare environment • Accelerated enrollment growth • Recent acquisition and new contract open new markets • Undervalued in comparison to its peers and history
New Regulations • 68B Industry Tax/Fee for duration of 3 years • 80% min. medical cost ratio • Mandatory rebates • Cuts to charges on Brand name Drugs under part D • Periodic actuarial adjustments to re- imbursement rates
Medical Care Ratio • Increase attributed to increase in consolidated benefit ratio in Humana’s Retail Segment.
Lead Analyst: Charles Paraboschi| Associates: Robert Kost & Peter Blicharz Humana, Inc. (HUM) Questions? Healthcare (Health care providers)